Spinosad clinical trials
How each study uses spinosad is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the spinosad studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 18 Jan 2011 · NATROBA · NDA 022408 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
ParaPRO LLC (4) · Aperta Biosciences, LLC (2) · Takeda (1) · Santen Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test spinosad.
- Jan 2027A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisPhase 2 · Aperta Biosciences, LLC
Studies
Open first, then newest update. How each study uses spinosad is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisNot yet recruitingPhase 2Aperta Biosciences, LLCNCT07904767Written as APT-001 topical ophthalmic ointment (spinosad)
- A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.CompletedPhase 2Aperta Biosciences, LLCNCT06720896Written as APT-001 topical ophthalmic ointment (spinosad)
- A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935CompletedPhase 1TakedaNCT02497235Written as [18F]MNI-792 (tracer)
- Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial DefectCompletedPhase 2Santen Pharmaceutical Co., Ltd.NCT00988494Written as DE-105 ophthalmic solution
- Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice InfestationCompletedPhase 4ParaPRO LLCNCT01660321Written as spinosad
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head LiceCompletedPhase 3ParaPRO LLCNCT00545168Written as Spinosad
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head LiceCompletedPhase 3ParaPRO LLCNCT00545753Written as Spinosad
- Phototoxicity Potential of NatrOVA Creme Rinse - 1%CompletedPhase 1ParaPRO LLCNCT00591331Written as Spinosad (the active ingredient in NatrOVA)
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call spinosad · ClinicalTrials.gg INT004279
- MeSH (NLM) C415329spinosadOne source NLM
- UNII (FDA) XPA88EAP6VSPINOSADConfirmed FDA, NLM
- RxNorm 299081One source FDA
- NCI Thesaurus C170381SpinosadOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C415329 | spinosad | One source NLM |
| UNII (FDA) | XPA88EAP6V | SPINOSAD | Confirmed FDA, NLM |
| RxNorm | 299081 | — | One source FDA |
| NCI Thesaurus | C170381 | Spinosad | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.